Aspire Biopharma Holdings, Inc.
ASBP · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1,948 | $206 | $1,347 | $4 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $37 |
| Inventory | $35 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $0 | -$37 |
| Total Curr. Assets | $2,403 | $989 | $1,966 | $148 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $6,669 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | -$6,669 |
| Total NC Assets | $0 | $0 | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $2,403 | $989 | $1,966 | $148 |
| Liabilities | – | – | – | – |
| Payables | $1,061 | $1,352 | $1,432 | $310 |
| Short-Term Debt | $8,625 | $8,473 | $6,764 | $1,267 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $3,908 | $0 | $0 | $111 |
| Total Curr. Liab. | $13,861 | $10,557 | $8,869 | $1,688 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $10 | $49 | $49 | $0 |
| Total NC Liab. | $10 | $49 | $49 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $13,870 | $10,606 | $8,918 | $1,688 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $5 | $5 | $5 | $22 |
| Retained Earnings | -$22,550 | -$20,700 | -$18,719 | -$2,777 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | -$11,467 | -$9,617 | -$6,953 | -$1,540 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $2,403 | $989 | $1,966 | $148 |
| Net Debt | $6,676 | $8,267 | $5,418 | $1,263 |